الفهرس 
ذOnly 14 pages are availabe for public view
 |  | from | 117 |  |  |
| | | from | 117 | | |
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in females, especially in women of reproductive age. The worldwide prevalence of PCOS is estimated to be between 8 13% of women of reproductive age and 6– 18% of adolescent girls depending on the diagnostic criteria used and the population studied 1. In Egypt, it is estimated that the prevalence of PCOS is 13% in fertile and 37.5% in secondary infertile patients.2 The term ‘‘polycystic ovarian syndrome’’ does not fully or accurately reflect the complexity of this disorder given its very broad spectrum of clinical manifestations and associated morbidities. Patients with PCOS demonstrate reproductive abnormalities, marked insulin resistance, increased risk for type 2 diabetes mellitus, coronary heart disease, atherogenic dyslipidemia, cerebrovascular morbidity, and anxiety and depression 3.